the patient's last menstrual period was 15 days back. No other significant history was present. Chest X-ray revealed no abnormality. Ultrasonography (USG) abdomen revealed chronic calculus cholecystitis. No other abnormality was detected on abdominal USG. Antiepileptics and antiedema measures were started.
On the basis of clinical presentation and CT brain findings, a working diagnosis of the vascular lesion was made. A CT angiogram brain was performed, which did not reveal any vascular etiology [ Figure 1b ]. Cerebral digital subtraction angiography (DSA) was then performed, which did not show any arteriovenous malformation (AVM) or aneurysm [ Figure 1c ]. A contrast magnetic resonance imaging (MRI) brain with MR spectroscopy (MRS) was performed, which revealed a hemorrhagic lesion [ Figure 2a ]. MRS findings were inconclusive possibly due to hemorrhage [ Figure 2b ]. No abnormality was detected on contrast-enhanced CT (CECT) abdomen and chest.
A craniotomy was planned with the aim of achieving a tissue-based diagnosis and gross total excision of the
Case Report

Introduction
C
horiocarcinoma is a tumor of trophoblastic tissue, which usually follows molar pregnancy and less commonly term pregnancy, ectopic pregnancy, or spontaneous abortion. [1] It metastasizes to lung, liver, and, less frequently, brain. [2] Intracerebral hemorrhage (ICH) as an initial manifestation in an apparently healthy female is a rare presentation and presents a diagnostic difficulty. [1, 3] The authors present the case summary of an adult female who presented with intracranial hemorrhage. Clinical history and initial investigations were inconclusive regarding the etiology of hemorrhage.
Case Report
A 32-year-old female had sudden-onset severe headache associated with vomiting. The patient was admitted in the emergency department. On admission, computed tomography (CT) brain was performed, which revealed a hemorrhagic lesion in the right parieto-occipital region [ Figure 1a] . The patient was then referred to the neurosurgery department for further management.
On admission to the neurosurgery unit, the patient's Glasgow Coma Scale score was 15/15, and the patient had no neurological deficit. The patient was married and had two children. The patient had a medical termination of pregnancy 2 years back. At the time of admission, Departments of Neurosurgery and 2 Pathology, SMS Medical College, lesion. The craniotomy was performed, which revealed a superficial cortical lesion with areas of hemorrhage. No feeding vessels or unexpected hemorrhage were encountered during the procedure. Gross total excision of the hemorrhagic lesion was performed. The patient had uneventful intraoperative and postoperative course. Postoperative contrast MRI was performed, which showed some residual tumor [ Figure 2c ].
Histopathological examination and immunohistochemistry revealed choriocarcinoma [ Figure 3 ]. Serum beta-human chorionic gonadotropin (β-hCG) level was estimated on postoperative day 4, which was found to be highly elevated [ Table 1 ]. The case was discussed in the institute's tumor board meeting regarding further management, and chemotherapy was started. The patient received cisplatin, etoposide, and bleomycin combination chemotherapy and whole-brain radiotherapy. The patient is without any neurological deficit at 4-month follow-up, with serum β-hCG values within reference interval [ Table 1 ].
Discussion
Diagnostic workup of a nontraumatic hemorrhage is a frequently performed exercise in neurosurgical practice. Stroke, aneurysm, AVM, and tumoral hemorrhages commonly present with nontraumatic ICH. In a published case report of choriocarcinoma, the authors emphasized the difficulty encountered in making a diagnosis in cases with intracranial hemorrhagic metastasis. [3] In the present case, CECT, MRI, and DSA ruled out aneurysm, AVM, and cortical venous thrombosis, which are possible common causes in a young woman, but failed to suggest an etiological diagnosis.
In a study from India, Suresh et al. reported ten cases of unsuspecting choriocarcinoma metastasizing to brain. [4] In agreement with this study, accurate diagnosis can only be made after resection of blood clots. This highlights the necessity for craniotomy and subsequent submission of specimen (blood clots) for histopathological examination. Suction evacuation should not be used in the removal of ICH in cases when tumor hemorrhage is suspected as it may lead to loss of tumor tissue. β-hCG levels are known to have diagnostic as well as prognostic value. [1] In the present case, clinical history, chest X-ray, and USG abdomen study did not raise suspicion for primary malignancy. In the authors' opinion, routine use of β-hCG in the diagnostic algorithm in cases of ICH is not recommended. However, in a young woman of reproductive age group, β-hCG estimation may be beneficial, especially when other common causes are excluded based on the clinical history and other investigations or tumor hemorrhage is suspected.
Choriocarcinoma is an aggressive but chemosensitive tumor, which may present as brain metastasis. Cerebral metastasis is considered a poor prognostic factor and combination chemotherapy is advocated. [5] In a study, Xiao et al. presented a single-institute experience in the management of patients with brain metastasis from gestational trophoblastic neoplasia. In their study, on univariate analysis, craniotomy was a favorable prognostic factor. [6] Conclusion Choricarcinoma is a rare tumor and initial presentation as intracranial hemorrhage presents a diagnostic difficulty. Serum β-hCG estimation may help in preoperative diagnosis in reproductive age group females. Suction should not be used for the removal of ICH when tumor hemorrhage is suspected. Craniotomy followed by chemotherapy and radiotherapy may improve outcome in a patient with brain metastasis of choriocarcinoma.
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